Amyloid-β-peptides (Aβ), which are typical of Alzheimer’s disease, have anti-angiogenic effects by binding to VEGFR-2 and preventing VEGF binding [28]. This evidence concerns the gene VEGFA and early-onset autosomal dominant Alzheimer disease.